Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Bonelli, RM; Niederwieser, G; Diez, J; Gruber, A; Költringer, P.
Pramipexole ameliorates neurologic and psychiatric symptoms in a Westphal variant of Huntington's disease.
Clin Neuropharmacol. 2002; 25(1):58-60
Doi: 10.1097%2F00002826-200201000-00011
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Bonelli Raphael
- Co-Autor*innen der Med Uni Graz
- Gruber Anna
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Levodopa is recommended as a therapeutic approach for patients with the hypokinetic-rigid, Westphal variant of Huntington's disease, but no guidelines are available for the case of nonrespondence to levodopa. In this study, however, we report a 34-year-old woman with this rare variant who showed a clear-cut improvement in motor function and depressive symptoms after treatment with pramipexole, a new dopamine agonist.
- Find related publications in this database (using NLM MeSH Indexing)
- Adult -
- Benserazide - administration and dosage
- Benzothiazoles - administration and dosage
- Depression - drug therapy
- Dopamine Agents - administration and dosage
- Dopamine Agonists - administration and dosage
- Drug Therapy, Combination - administration and dosage
- Female - administration and dosage
- Humans - administration and dosage
- Huntington Disease - diagnosis
- Hypokinesia - drug therapy
- Levodopa - administration and dosage
- Muscle Rigidity - drug therapy
- Severity of Illness Index - drug therapy
- Thiazoles - administration and dosage
- Find related publications in this database (Keywords)
- dopamine agonists
- pramipexole
- Huntington's disease
- Westphal variant